Barclays analyst Michael Leithead lowered the firm’s price target on Eastman Chemical (EMN) to $85 from $108 and keeps an Equal Weight rating on the shares following the Q1 report. An earnings reset from tariff exposure, lower methanolysis revenue, and Fibers destocking will “likely put a near-term pause on an equity story that we think had been growing in investor interest,” the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
- Promising Outlook for Eastman Chemical Amid Challenges: Buy Rating Supported by Strategic Initiatives and Strong Segment Performance
- Eastman Chemical price target lowered to $93 from $97 at BofA
- Eastman Chemical: Buy Rating Affirmed Amid Strong Financial Resilience and Attractive Risk/Reward Profile
- Eastman Chemical price target lowered to $115 from $125 at Morgan Stanley
- Eastman Chemical: Defensive Strength and Growth Potential Amid Tariff Concerns and Project Risks